Is Rapport Therapeutics, Inc. Common Stock (RAPP) a Buy, Sell, or Hold?
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP
$41.46 USD
$0.87 (2.14%)
- Volume
- 404.83K
- Average Volume
- 385.25K
- Market Capitalization
- $1.51B
- P/E Ratio
- -15.95
- Dividend Yield
- 0.00%
- Price Target
- $56.00
- Year High
- $43.76
- Year Low
- $13.43
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.08
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
22
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
68
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.19M
RAPP Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
RAPP Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Gault Cheryl | officer: Chief Operating Officer | 2026-06-30 | S-Sale | 40.0914 | 2026-07-01 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-06-30 | S-Sale | 41.3934 | 2026-07-01 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-06-30 | S-Sale | 42.1722 | 2026-07-01 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-06-30 | S-Sale | 43.1547 | 2026-07-01 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-06-29 | S-Sale | 39.7688 | 2026-07-01 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-06-29 | S-Sale | 40.3375 | 2026-07-01 |
| MARAGANORE JOHN | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| PEREZ ROBERT J | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| PAUL STEVEN M | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| Silva Paul M | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| HEALY JAMES | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| Huber Reid M | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| Young Wendy B. | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| Sanchez Ramiro | director | 2026-06-10 | A-Award | 35.21 | 2026-06-10 |
| Third Rock Ventures V, L.P. | 10 percent owner | 2026-05-26 | S-Sale | 40.047 | 2026-05-28 |
| Third Rock Ventures V, L.P. | 10 percent owner | 2026-05-11 | S-Sale | 40.244 | 2026-05-13 |
| Third Rock Ventures V, L.P. | 10 percent owner | 2026-05-07 | S-Sale | 40.121 | 2026-05-11 |
| Third Rock Ventures V, L.P. | 10 percent owner | 2026-05-08 | S-Sale | 40.306 | 2026-05-11 |
| Third Rock Ventures V, L.P. | 10 percent owner | 2026-04-17 | S-Sale | 40.317 | 2026-04-21 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-04-17 | S-Sale | 39.9923 | 2026-04-21 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-04-10 | S-Sale | 34.98 | 2026-04-14 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-04-13 | S-Sale | 34.974 | 2026-04-14 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-04-14 | S-Sale | 35.0781 | 2026-04-14 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-04-08 | S-Sale | 34.9 | 2026-04-09 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-03-30 | S-Sale | 28.0401 | 2026-03-31 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-03-30 | S-Sale | 28.553 | 2026-03-31 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-03-25 | S-Sale | 29.9906 | 2026-03-26 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-03-05 | S-Sale | 28.93 | 2026-03-09 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-02-18 | S-Sale | 29.0516 | 2026-02-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-02-18 | S-Sale | 29.7983 | 2026-02-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-02-18 | S-Sale | 29.0443 | 2026-02-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-02-18 | S-Sale | 29.7965 | 2026-02-19 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-17 | S-Sale | 28.0211 | 2026-02-19 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-19 | M-Exempt | 1.8 | 2026-02-19 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-17 | S-Sale | 28.9497 | 2026-02-19 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-17 | S-Sale | 29.5944 | 2026-02-19 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-19 | M-Exempt | 1.8 | 2026-02-19 |
| Sevigny Jeffrey | officer: Chief Medical Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Ignelzi Troy A. | officer: Chief Financial Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Bredt David | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Gault Cheryl | officer: Chief Operating Officer | 2026-02-02 | A-Award | 27.75 | 2026-02-04 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-01-20 | S-Sale | 26.1158 | 2026-01-22 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2026-01-20 | S-Sale | 26.114 | 2026-01-22 |
| Bredt David | officer: Chief Scientific Officer | 2026-01-15 | S-Sale | 26.8255 | 2026-01-16 |
| Bredt David | officer: Chief Scientific Officer | 2026-01-15 | S-Sale | 27.4 | 2026-01-16 |
| Bredt David | officer: Chief Scientific Officer | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| Bredt David | officer: Chief Scientific Officer | 2025-12-31 | S-Sale | 30.0499 | 2026-01-05 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| Yeleswaram Krishnaswamy | officer: Chief Development Officer | 2025-12-31 | S-Sale | 30.05 | 2026-01-05 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 28.8378 | 2025-12-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 30.0365 | 2025-12-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 31.036 | 2025-12-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 28.8425 | 2025-12-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 30.0378 | 2025-12-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-12-17 | S-Sale | 31.0396 | 2025-12-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-12-15 | S-Sale | 29.9469 | 2025-12-16 |
| Bredt David | officer: Chief Scientific Officer | 2025-12-15 | S-Sale | 30.6772 | 2025-12-16 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-11-26 | M-Exempt | 1.8 | 2025-12-01 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-11-26 | S-Sale | 30.0973 | 2025-12-01 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-11-26 | M-Exempt | 1.8 | 2025-12-01 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-11-17 | S-Sale | 24.9246 | 2025-11-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-11-17 | S-Sale | 25.4303 | 2025-11-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-11-17 | S-Sale | 24.9107 | 2025-11-18 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-11-17 | S-Sale | 25.437 | 2025-11-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-11-17 | S-Sale | 24.8399 | 2025-11-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-11-17 | S-Sale | 25.3922 | 2025-11-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-10-15 | S-Sale | 25.7329 | 2025-10-16 |
| Bredt David | officer: Chief Scientific Officer | 2025-10-15 | S-Sale | 26.1641 | 2025-10-16 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-10-15 | S-Sale | 25.724 | 2025-10-16 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-10-15 | S-Sale | 26.1392 | 2025-10-16 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-10-15 | S-Sale | 25.746 | 2025-10-16 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-10-15 | S-Sale | 26.1721 | 2025-10-16 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-09-17 | S-Sale | 26.299 | 2025-09-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-09-17 | S-Sale | 26.8745 | 2025-09-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-09-17 | S-Sale | 26.3019 | 2025-09-19 |
| Ceesay Abraham | director, officer: Chief Executive Officer | 2025-09-17 | S-Sale | 27.0429 | 2025-09-19 |
| Bredt David | officer: Chief Scientific Officer | 2025-09-15 | S-Sale | 23.8841 | 2025-09-17 |
| Bredt David | officer: Chief Scientific Officer | 2025-09-15 | S-Sale | 24.6583 | 2025-09-17 |
| Huber Reid M | director | 2025-09-12 | P-Purchase | 24.4791 | 2025-09-15 |
| PAUL STEVEN M | director | 2025-09-12 | P-Purchase | 24.9712 | 2025-09-15 |
| PAUL STEVEN M | director | 2025-09-12 | P-Purchase | 24.4996 | 2025-09-15 |
| Young Wendy B. | director | 2025-09-11 | P-Purchase | 22.6 | 2025-09-11 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-09-08 | M-Exempt | 1.8 | 2025-09-10 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-09-08 | S-Sale | 38.33 | 2025-09-10 |
| Gault Cheryl | officer: Chief Operating Officer | 2025-09-08 | M-Exempt | 1.8 | 2025-09-10 |
| Bredt David | officer: Chief Scientific Officer | 2025-08-15 | S-Sale | 14.9769 | 2025-08-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-08-15 | S-Sale | 15.79 | 2025-08-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-07-15 | S-Sale | 13.9955 | 2025-07-16 |
| Sanchez Ramiro | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| Young Wendy B. | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| MARAGANORE JOHN | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| HEALY JAMES | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| PEREZ ROBERT J | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| Huber Reid M | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| PAUL STEVEN M | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-06-16 | S-Sale | 11.0026 | 2025-06-18 |
| Silva Paul M | director | 2025-06-17 | A-Award | 10.95 | 2025-06-18 |
| Bredt David | officer: Chief Scientific Officer | 2025-05-15 | S-Sale | 9.5602 | 2025-05-19 |